Bilateral Rhomboid Intercostal Block Versus Erector Spinae Plane Block for Perioperative Analgesia in Patients Undergoing Bilateral Reduction Mammoplasty

11408//15-1-2024

Bilateral reduction mammoplasty is one of the most commonly performed breast surgery. The Postoperative pain following it should be minimized. Opioid administration for acute pain after reduction mammoplasty surgery has many side effects. Regional block techniques such as paravertebral block and thoracic epidural anesthesia have possible complications and technical difficulties. The new alternative regional techniques such as erector spinae plane block and rhomboid intercostal plane block are clinical trials for providing a safe, easy, and painless anesthetic procedure with adequate postoperative analgesia for a large section of patients undergoing thoracic surgeries.

2024-02-01

2024-08-01

2024-09-01

Recruiting

72

Inclusion Criteria: * Patient acceptance. * Age 21-50 years old. * BMI ≤ 30 kg/m2 * ASA I - II. * Elective bilateral reduction mammoplasty surgery under general anesthesia. * Duration of surgery within five hours Exclusion Criteria: * Patients on anti-platelet, anticoagulant, or B blocker drugs. * Patients with acute decompensated heart failure, hypertension, heart block, coronary disease, Asthma * History of allergy to the local anesthetics (LA) agents used in this study, * Skin lesion at the needle insertion site, * Those with bleeding disorders, sepsis, liver disease, psychiatric disorders, and pregnancy.

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'computer generating random numbers, the patients will be allocated into three equal groups: Group C: (control group) patients will receive a sham block with 20 ml of normal saline on each side followed by general anesthesia.\n\nGroup E: patients will receive an Erector spinea plane block with 20 ml of bupivacaine 0.25% on each side followed by general anesthesia.\n\nGroup R: patients will receive rhomboid intercostal nerve block with 20 ml of bupivacaine 0.25% on each side followed by general anesthesia.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'Double (Participant, Outcomes Assessor) double-blinded(participants and outcome assessors)', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 72, 'type': 'ESTIMATED'}}

2024-01-26